Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

A large fall of pHi is prominent in myocardial ischaemia, where it causes acute contractile failure, abnormal Ca2+ signalling and arrhythmia. We have a particular interest in understanding how changes in pHi influence the probability and properties of pro-arrhythmic Ca2+ waves, both via direct effects on Ca2+-handling proteins such as the ryanodine receptor, and indirectly via effects on Na+i.

We have increasing evidence for a fundamental remodelling of the pHi regulatory system in maladaptive hypertrophy and heart failure, which may contribute to alterations in Ca2+ handling.  Such changes in Ca2+ handling have long been considered to play a causal role in the development of these pathologies, contributing to changes in gene expression as well as in contractility and electrical behaviour. Therefore we are actively pursuing research into a link between pH dysregulation and development of hypertrophy and heart failure. This work is funded by a 5-year British Heart Foundation Programme Grant.